SPMXF (Supermax Bhd) EBITDA per Share: $-0.03 (TTM As of Mar. 2026)


SPMXF Supermax Corp Bhd SPMXF
51 GF Score
Price $0.15
GF Value $0.37
! 6 Warning Signs
View Full Analysis

What is Supermax Bhd EBITDA per Share?

Supermax Bhd SPMXF 51 EBITDA per Share is $-0.03 as of Mar. 2026. GuruFocus rates SPMXF with a GF Score™ of 51/100 and a GF Value™ of $0.37. The stock has 6 warning signs investors should review. Among 696 Medical Devices & Instruments companies, Supermax Bhd ranks worse than 143678.02% on this metric.

Supermax Bhd's EBITDA per Share for the three months ended in Mar. 2026 was $-0.00. Its EBITDA per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.03.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per Share growth rate using EBITDA per Share data.

The historical rank and industry rank for Supermax Bhd's EBITDA per Share or its related term are showing as below:

During the past 13 years, the highest 3-Year average EBITDA per Share Growth Rate of Supermax Bhd was 190.60% per year. The lowest was -13.60% per year. And the median was 10.80% per year.

SPMXF's 3-Year EBITDA Growth Rate is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 7.8
* Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.

Supermax Bhd's EBITDA for the three months ended in Mar. 2026 was $-9.6 Mil.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

During the past 13 years, the highest 3-Year average EBITDA Growth Rate of Supermax Bhd was 186.10% per year. The lowest was -6.60% per year. And the median was 13.70% per year.


Supermax Bhd  (OTCPK:SPMXF) EBITDA per Share Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals EBIT. EBIT is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost, it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies.


Supermax Bhd EBITDA per Share Related Terms


Supermax Bhd EBITDA per Share Historical Data

* Premium members only.

The historical data trend for Supermax Bhd's EBITDA per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Supermax Bhd EBITDA per Share Chart

Supermax Bhd Annual Data
Trend Dec15 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
EBITDA per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.38 0.08 -0.01 -0.01 -0.01

Supermax Bhd Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBITDA per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.00 -0.01 -0.01 -0.00 -0.00
SPMXF
51GF Score
Supermax Corp Bhd SPMXF
EBITDA per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Supermax Bhd EBITDA per Share Calculation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Supermax Bhd's EBITDA per Share for the fiscal year that ended in Jun. 2025 is calculated as

EBITDA per Share(A: Jun. 2025 )
=EBITDA/Shares Outstanding (Diluted Average)
=-26.259/3082.588
=-0.01

Supermax Bhd's EBITDA per Share for the quarter that ended in Mar. 2026 is calculated as

EBITDA per Share(Q: Mar. 2026 )
=EBITDA/Shares Outstanding (Diluted Average)
=-9.583/3082.588
=-0.00

EBITDA per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA per Share →
What does a EBITDA per Share of $-0.03 mean?
Supermax Bhd (SPMXF) has a EBITDA per Share of $-0.03 as of Mar. 2026. EBITDA per share is the per-share amount of earnings before interest, taxes, depreciation and amortization. View historical data on Supermax Bhd and its competitors. According to the industry distribution chart, Supermax Bhd ranks #999999 out of 696 companies in the Medical Devices & Instruments industry.
Is Supermax Bhd's EBITDA per Share too high?
Supermax Bhd's current EBITDA per Share is $-0.03. Based on the distribution chart, Supermax Bhd ranks #999999 out of 696 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Supermax Bhd has a GF Score™ of 51/100, reflecting its overall financial health beyond just this single metric.
How does Supermax Bhd's EBITDA per Share compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Supermax Bhd ranks #999999 out of 696 companies for EBITDA per Share. This places Supermax Bhd in the lower half of its industry. The industry median EBITDA per Share is 7.80. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA per Share for a Medical Devices & Instruments company?
The median EBITDA per Share among Medical Devices & Instruments companies is 7.80, based on 696 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA per Share significantly above this median, while those in the bottom quartile fall well below. However, EBITDA per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA per Share mean?
A high EBITDA per Share can signal that a stock is expensive relative to its fundamentals. EBITDA per share is the per-share amount of earnings before interest, taxes, depreciation and amortization. View historical data on Supermax Bhd and its competitors. For the Medical Devices & Instruments industry, the median EBITDA per Share is 7.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Supermax Bhd's current EBITDA per Share is $-0.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Supermax Bhd stock overvalued right now?
Supermax Bhd (SPMXF) has a current EBITDA per Share of $-0.03. The stock's GF Value™ is $0.37, compared to a current price of $0.15 — trading 59.5% below its estimated fair value. The current EBITDA per Share is $-0.03. Supermax Bhd's overall GF Score™ is 51/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA per Share calculated?
EBITDA per Share is calculated from a company's financial statements. For Supermax Bhd (SPMXF), the current EBITDA per Share is $-0.03 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Supermax Bhd (SPMXF) Overvalued in 2026?

Based on GuruFocus' analysis, Supermax Bhd stock appears to be undervalued. The current stock price of $0.15 is trading 59.5% below its estimated GF Value™ of $0.37.

Key valuation signals for SPMXF:

  • EBITDA per Share: $-0.03
  • GF Value™: $0.37 vs. price of $0.15 (59.5% below fair value)
  • GF Score™: 51/100 with 6 warning signs

No single metric tells the full story. See the SPMXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Supermax Bhd Business Description

Other Exchanges 7106:Malaysia
Address Lot 38, Putra Industrial Park, Bukit Rahman Putra, Sungai Buloh, SGR, MYS, 40160
Supermax Corp Bhd is an investment holding company. Along with its subsidiaries, the company operates as an international manufacturer, distributor, and marketer of high-quality medical gloves and contact lenses. It offers various types of latex gloves, which are exported to numerous countries. The company is organized into the following reportable operating segments: manufacturing of gloves, which generates the majority of revenue; investment holding; trading of gloves; and others. Geographically, it derives the majority of its revenue from Europe, with the remainder coming from Africa, Asia and Oceania, and North, Central, and South America.
51GF Score

Get the complete analysis for SPMXF

EBITDA per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.15
Price
$0.37
GF Value